# Rapid Micro Biosystems, Inc.: filings

RPID · Nasdaq · CIK 1380106 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rpid.md) · [Financials](/companies/rpid/financials.md) · [Filings](/companies/rpid/filings.md) · [Insiders](/companies/rpid/insiders.md)

## Reports and events: 79 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 129, 8-K 47, 3 20, 144 18, 10-Q 16, D 8, SC 13G 8, SC 13G/A 8, S-8 6, UPLOAD 6, 10-K 5, CORRESP 5, DEF 14A 5, DEFA14A 5, ARS 4, SCHEDULE 13G/A 3, SD 3, 424B5 2, 8-A12B 2, DRS/A 2, DRSLTR 2, EFFECT 2, SEC STAFF LETTER 2, 10-K/A 1, 424B3 1, 424B4 1, 4/A 1, CERT 1, D/A 1, DRS 1, PRE 14A 1, REGDEX 1, S-1 1, S-1/A 1, S-1MEF 1, S-3 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 07:33 ET | [10-Q](/filings/0001380106-26-000101.md) | Quarterly report, period 2026-06-30 | 0001380106-26-000101 |
| 2026-08-07 | 07:02 ET | [8-K](/filings/0001380106-26-000097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-26-000097 |
| 2026-05-28 | 16:14 ET | [8-K](/filings/0001380106-26-000085.md) | 5.07 Shareholder vote results | 0001380106-26-000085 |
| 2026-05-19 | 17:13 ET | [8-K](/filings/0001104659-26-063936.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-063936 |
| 2026-05-15 | 07:35 ET | [10-Q](/filings/0001380106-26-000075.md) | Quarterly report, period 2026-03-31 | 0001380106-26-000075 |
| 2026-05-13 | 16:33 ET | [8-K](/filings/0001380106-26-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-26-000067 |
| 2026-04-08 | 16:36 ET | [DEF 14A](/filings/0001380106-26-000057.md) | Proxy statement, period 2026-05-21 | 0001380106-26-000057 |
| 2026-03-27 | 16:34 ET | [8-K](/filings/0001380106-26-000045.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001380106-26-000045 |
| 2026-03-12 | 16:53 ET | [10-K](/filings/0001380106-26-000034.md) | Annual report, period 2025-12-31 | 0001380106-26-000034 |
| 2026-03-12 | 07:02 ET | [8-K](/filings/0001380106-26-000029.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001380106-26-000029 |
| 2026-01-13 | 16:16 ET | [8-K](/filings/0001380106-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-26-000007 |
| 2025-11-07 | 17:06 ET | [10-Q](/filings/0001380106-25-000200.md) | Quarterly report, period 2025-09-30 | 0001380106-25-000200 |
| 2025-11-07 | 06:03 ET | [8-K](/filings/0001380106-25-000195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-25-000195 |
| 2025-08-19 | 17:39 ET | [SCHEDULE 13D](/filings/0001380106-25-000185.md) | Ownership report, active investor | 0001380106-25-000185 |
| 2025-08-12 | 17:15 ET | [10-Q](/filings/0001380106-25-000174.md) | Quarterly report, period 2025-06-30 | 0001380106-25-000174 |
| 2025-08-12 | 06:33 ET | [8-K](/filings/0001380106-25-000169.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001380106-25-000169 |
| 2025-06-17 | 17:30 ET | [8-K](/filings/0001380106-25-000153.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001380106-25-000153 |
| 2025-05-23 | 16:21 ET | [8-K](/filings/0001380106-25-000114.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001380106-25-000114 |
| 2025-05-09 | 16:21 ET | [10-Q](/filings/0001380106-25-000102.md) | Quarterly report, period 2025-03-31 | 0001380106-25-000102 |
| 2025-05-09 | 07:06 ET | [8-K](/filings/0001380106-25-000099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-25-000099 |
| 2025-04-08 | 16:49 ET | [DEF 14A](/filings/0001380106-25-000089.md) | Proxy statement, period 2025-05-22 | 0001380106-25-000089 |
| 2025-03-04 | 16:24 ET | [8-K](/filings/0001380106-25-000066.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001380106-25-000066 |
| 2025-02-28 | 16:30 ET | [10-K](/filings/0001380106-25-000058.md) | Annual report, period 2024-12-31 | 0001380106-25-000058 |
| 2025-02-28 | 06:33 ET | [8-K](/filings/0001380106-25-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-25-000050 |
| 2025-02-27 | 16:23 ET | [8-K](/filings/0001380106-25-000043.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001380106-25-000043 |
| 2025-01-16 | 08:33 ET | [8-K](/filings/0001380106-25-000015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001380106-25-000015 |
| 2025-01-14 | 16:17 ET | [8-K](/filings/0001380106-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-25-000009 |
| 2024-11-12 | 09:13 ET | [8-K](/filings/0001380106-24-000202.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001380106-24-000202 |
| 2024-11-07 | 17:25 ET | [10-Q](/filings/0001380106-24-000197.md) | Quarterly report, period 2024-09-30 | 0001380106-24-000197 |
| 2024-11-01 | 07:02 ET | [8-K](/filings/0001380106-24-000191.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001380106-24-000191 |
| 2024-08-02 | 16:19 ET | [10-Q](/filings/0001380106-24-000166.md) | Quarterly report, period 2024-06-30 | 0001380106-24-000166 |
| 2024-08-02 | 07:02 ET | [8-K](/filings/0001380106-24-000162.md) | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001380106-24-000162 |
| 2024-05-24 | 17:24 ET | [8-K](/filings/0001380106-24-000132.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001380106-24-000132 |
| 2024-05-03 | 16:11 ET | [10-Q](/filings/0001380106-24-000127.md) | Quarterly report, period 2024-03-31 | 0001380106-24-000127 |
| 2024-05-03 | 07:03 ET | [8-K](/filings/0001380106-24-000125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-24-000125 |
| 2024-04-09 | 16:09 ET | [DEF 14A](/filings/0001380106-24-000114.md) | Proxy statement, period 2024-05-23 | 0001380106-24-000114 |
| 2024-03-01 | 16:38 ET | [10-K](/filings/0001380106-24-000073.md) | Annual report, period 2023-12-31 | 0001380106-24-000073 |
| 2024-03-01 | 06:33 ET | [8-K](/filings/0001380106-24-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-24-000058 |
| 2024-02-02 | 17:28 ET | [8-K](/filings/0001380106-24-000014.md) | 3.01 Delisting notice | 0001380106-24-000014 |
| 2024-01-10 | 08:06 ET | [8-K](/filings/0001380106-24-000009.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001380106-24-000009 |
| 2023-11-03 | 16:16 ET | [10-Q](/filings/0001380106-23-000177.md) | Quarterly report, period 2023-09-30 | 0001380106-23-000177 |
| 2023-11-03 | 07:03 ET | [8-K](/filings/0001380106-23-000173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-23-000173 |
| 2023-09-26 | 16:40 ET | [8-K](/filings/0001380106-23-000165.md) | 8.01 Other events | 0001380106-23-000165 |
| 2023-09-19 | 16:47 ET | [8-K](/filings/0001380106-23-000161.md) | 3.01 Delisting notice | 0001380106-23-000161 |
| 2023-08-04 | 16:32 ET | [10-Q](/filings/0001380106-23-000148.md) | Quarterly report, period 2023-06-30 | 0001380106-23-000148 |
| 2023-08-04 | 07:05 ET | [8-K](/filings/0001380106-23-000142.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001380106-23-000142 |
| 2023-07-18 | 17:25 ET | [8-K](/filings/0001380106-23-000130.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001380106-23-000130 |
| 2023-05-15 | 19:19 ET | [10-K/A](/filings/0001380106-23-000116.md) | Annual report, amended, period 2022-12-31 | 0001380106-23-000116 |
| 2023-05-09 | 17:28 ET | [10-Q](/filings/0001380106-23-000097.md) | Quarterly report, period 2023-03-31 | 0001380106-23-000097 |
| 2023-05-08 | 17:23 ET | [8-K](/filings/0001380106-23-000093.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001380106-23-000093 |

Page 1 of 2. [Older](/companies/rpid/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.